Weil is advising Shandong Weigao Group Medical Polymer Company Limited (Weigao) and Argon Medical Devices Holdings, Inc. (Argon) on the refinancing of Argon’s existing debt. Argon is a U.S.-based manufacturer of medical devices and was acquired by Weigao, a Chinese developer, manufacturer and seller of single-use medical devices, in 2018. The refinancing comprises a New York law senior secured $375 million Tranche A Term and Revolver Facilities and an English law senior secured $75 million Tranche B Term Facility, which were marketed to lenders in the U.S. and Europe, respectively.
The Weil team is led by Hong Kong banking and finance partner Soo-Jin Shim and includes associates Kevin Yao, Rick Wei, Carolyn Ho and Max Maisonrouge.